EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Knowing and Naming: Phage Annotation and Nomenclature for Phage Therapy

Susanna R Grigson iD, Sarah K Giles iD, Robert A Edwards iD, Bhavya Papudeshi iD

Clinical Infectious Diseases · 02.11.2023 · 77 (Supplement_5) · S352-S359

DOI: 10.1093/cid/ciad539 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.11.2023. Verfasst von Susanna R Grigson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Flinders Accelerator for Microbiome Exploration, College of Science and Engineering, Flinders University, Adelaide, Australia. Hauptthemen laut MEDLINE: Bacteriophages, Phage Therapy, Microbiota. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Australian Research Council, Gordon and Betty Moore Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteriophages, or phages, are viruses that infect bacteria shaping microbial communities and ecosystems. They have gained attention as potential agents against antibiotic resistance. In phage therapy, lytic phages are preferred for their bacteria killing ability, while temperate phages, which can transfer antibiotic resistance or toxin genes, are avoided. Selection relies on plaque morphology and genome sequencing. This review outlines annotating genomes, identifying critical genomic features, and assigning functional labels to protein-coding sequences. These annotations prevent the transfer of unwanted genes, such as antimicrobial resistance or toxin genes, during phage therapy. Additionally, it covers International Committee on Taxonomy of Viruses (ICTV)-an established phage nomenclature system for simplified classification and communication. Accurate phage genome annotation and nomenclature provide insights into phage–host interactions, replication strategies, and evolution, accelerating our understanding of the diversity and evolution of phages and facilitating the development of phage-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriophagesPhage TherapyMicrobiotaHumansGenomicsBacteria

Stichwörter der Autor:innen

BacteriophagesTaxonomyantibiotic resistancegenomic featuresplaque morphologyprotein-coding sequences

Autor:innen und Institutionen

  • Flinders Accelerator for Microbiome Exploration, College of Science and Engineering, Flinders University, Adelaide, Australia.

ORCID-Profile: Susanna R Grigson, Sarah K Giles, Robert A Edwards, Bhavya Papudeshi

Förderung

  • NIDDK NIH HHS
  • Australian Research Council
  • Gordon and Betty Moore Foundation
  • Playford Trust

Zitieren

APA

Grigson, S. R., Giles, S. K., Edwards, R. A., & Papudeshi, B. (2023). Knowing and Naming: Phage Annotation and Nomenclature for Phage Therapy. Clinical Infectious Diseases, 77(Supplement_5), S352-S359. https://doi.org/10.1093/cid/ciad539

Vancouver

Grigson SR, Giles SK, Edwards RA, Papudeshi B. Knowing and Naming: Phage Annotation and Nomenclature for Phage Therapy. Clinical Infectious Diseases. 2023;77(Supplement_5):S352-S359. doi:10.1093/cid/ciad539

BibTeX
@article{Grigson2023,
  author = {Grigson, Susanna R and Giles, Sarah K and Edwards, Robert A and Papudeshi, Bhavya},
  title = {Knowing and Naming: Phage Annotation and Nomenclature for Phage Therapy},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {Supplement_5},
  pages = {S352--S359},
  doi = {10.1093/cid/ciad539}
}
Kostenlos starten →